HIF1A and central nervous system cancer: FCM was used to detect the proportion of CD133+CD15+ cells after culturing CD133-CD15- glioma cells in 1% O2 for 7 days, and the results showed that both CD133 expression and CD15 expression were significantly decreased in HIF1α-ko and HIF2α-ko cells compared with vector cells.